Our technology uses a unique mechanism of action to crosslink cell receptors, providing transformative solutions for patients, oncologists, and payers.
Location: United States
Employees: 11-50
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | Technology... | pivotcente... |